Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03255629 · ClinicalTrials.gov registry record · Phase 1
Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia
A Phase 1 study, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT03255629 is a Phase 1 study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 18 participants.
The verdict
NCT03255629, a Phase 1 study, has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
To assess the efficacy of a closed loop glucagon system to prevent and treat hypoglycemia occurring in patients with Post-Bariatric Hypoglycemia (PBH) in response to meals and exercise.
Interventions
- DRUG glucagon
- DEVICE Closed loop glucagon pump
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-09-19 |
| Est. Completion | 2018-08-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03255629
The ClinicalTrials.gov registry entry for NCT03255629 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which glucagon is the first listed.
NCT03255629 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03255629 about?
NCT03255629 is a clinical study titled "Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia". To assess the efficacy of a closed loop glucagon system to prevent and treat hypoglycemia occurring in patients with Post-Bariatric Hypoglycemia (PBH) in response to meals and exercise.
What is the current status of trial NCT03255629?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2017-09-19. Estimated completion is 2018-08-22.
What interventions are being tested in trial NCT03255629?
The interventions under investigation include: glucagon (DRUG), Closed loop glucagon pump (DEVICE).
Who is sponsoring clinical trial NCT03255629?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.